Patient Care

Circadian Health and Tenovi Announce Strategic Partnership to Expand Remote Patient Monitoring for Chronic Disease Management

Collaboration Integrates Next-Generation Remote Patient Monitoring Devices into Circadian's Virtual Specialty Care Platform, Enhancing Patient Outcomes and Reducing Costs WEST...

Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEARā„¢ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline

• COEP forms GEAR Therapeutics, as a majority-owned subsidiary, to advance GEAR-modified natural killer (NK) cells into first-in-human studies for...

Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQĀ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma

Enhanced assay granted approval by New York State’s Clinical Lab Evaluation Program (CLEP) for patients with DLBCL clonoSEQ is the...

Late-Breaking ESK-001 Phase 2 OLE Data Presented at 2025 AAD Annual Meeting Demonstrate Robust Clinical Responses Over 52-Weeks in Psoriasis

ESK-001 is a highly selective, next-generation oral tyrosine kinase 2 (TYK2) inhibitor currently under development in moderate-to-severe plaque psoriasis and...

error: Content is protected !!